Context matters: the psychoneurobiological determinants of placebo, nocebo and context-related effects in physiotherapy.

Giacomo Rossettini, Eleonora Maria Camerone, Elisa Carlino, Fabrizio Benedetti, Marco Testa
Author Information
  1. Giacomo Rossettini: Department of Neuroscience, Rehabilitation, Ophtalmology, Genetics, Maternal and Child Health, University of Genova, Campus Universitario di Savona, via Magliotto 2, 17100 Savona, Italy. ORCID
  2. Eleonora Maria Camerone: Department of Neuroscience, Rehabilitation, Ophtalmology, Genetics, Maternal and Child Health, University of Genova, Campus Universitario di Savona, via Magliotto 2, 17100 Savona, Italy.
  3. Elisa Carlino: Department of Neuroscience, University of Turin Medical School, Turin, Italy.
  4. Fabrizio Benedetti: Department of Neuroscience, University of Turin Medical School, Turin, Italy.
  5. Marco Testa: Department of Neuroscience, Rehabilitation, Ophtalmology, Genetics, Maternal and Child Health, University of Genova, Campus Universitario di Savona, via Magliotto 2, 17100 Savona, Italy.

Abstract

BACKGROUND: Placebo and nocebo effects embody psychoneurobiological phenomena where behavioural, neurophysiological, perceptive and cognitive changes occur during the therapeutic encounter in the healthcare context. Placebo effects are produced by a positive healthcare context; while nocebo effects are consequences of negative healthcare context. Historically, placebo, nocebo and context-related effects were considered as confounding elements for clinicians and researchers. In the last two decades this attitude started to change, and the understanding of the value of these effects has increased. Despite the growing interest, the knowledge and the awareness of using the healthcare context to trigger placebo and nocebo effects is currently limited and heterogeneous among physiotherapists, reducing their translational value in the physiotherapy field.
OBJECTIVES: To introduce the placebo, nocebo and context-related effects by: (1) presenting their psychological models; (2) describing their neurophysiological mechanisms; (3) underlining their impact for the physiotherapy profession; and (4) tracing lines for future researches.
CONCLUSION: Several psychological mechanisms are involved in placebo, nocebo and context-related effects; including expectation, learning processes (classical conditioning and observational learning), reinforced expectations, mindset and personality traits. The neurophysiological mechanisms mainly include the endogenous opioid, the endocannabinoid and the dopaminergic systems. Neuroimaging studies have identified different brain regions involved such as the dorsolateral prefrontal cortex, the rostral anterior cingulate cortex, the periaqueductal gray and the dorsal horn of spine. From a clinical perspective, the manipulation of the healthcare context with the best evidence-based therapy represents an opportunity to trigger placebo effects and to avoid nocebo effects respecting the ethical code of conduct. From a managerial perspective, stakeholders, organizations and governments should encourage the assessment of the healthcare context aimed to improve the quality of physiotherapy services. From an educational perspective, placebo and nocebo effects are professional topics that should be integrated in the university program of health and medical professions. From a research perspective, the control of placebo, nocebo and context-related effects offers to the scientific community the chance to better measure the impact of physiotherapy on different outcomes and in different conditions through primary studies.

Keywords

References

  1. Pain. 2013 Aug;154(8):1312-7 [PMID: 23725779]
  2. Hum Brain Mapp. 2015 May;36(5):1648-61 [PMID: 25529840]
  3. Phys Ther. 2014 Apr;94(4):477-89 [PMID: 24309616]
  4. Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15959-64 [PMID: 23019380]
  5. Musculoskelet Sci Pract. 2018 Feb;33:1-10 [PMID: 29055216]
  6. J Clin Nurs. 2019 May;28(9-10):1966-1978 [PMID: 30706543]
  7. Pain. 2010 Jul;150(1):59-65 [PMID: 20399560]
  8. Nat Rev Rheumatol. 2014 Jun;10(6):348-55 [PMID: 24567065]
  9. Am J Clin Hypn. 2015 Jan;57(3):267-84 [PMID: 25928679]
  10. Pain Med. 2018 Jun 1;19(6):1156-1169 [PMID: 29016984]
  11. Perspect Med Educ. 2018 Aug;7(4):256-263 [PMID: 29704167]
  12. Man Ther. 2015 Feb;20(1):171-5 [PMID: 25261090]
  13. J Psychosom Res. 2005 Feb;58(2):121-7 [PMID: 15820839]
  14. BMC Med Educ. 2017 Nov 15;17(1):211 [PMID: 29141616]
  15. Eur J Phys Rehabil Med. 2018 Jun;54(3):500-501 [PMID: 29144109]
  16. Annu Rev Clin Psychol. 2017 May 8;13:73-98 [PMID: 28375723]
  17. J Pers Soc Psychol. 2013 Apr;104(4):716-33 [PMID: 23437923]
  18. Cortex. 2014 Nov;60:3-9 [PMID: 24457096]
  19. Handb Clin Neurol. 2017;139:597-606 [PMID: 27719874]
  20. Pain. 1997 Aug;72(1-2):107-13 [PMID: 9272794]
  21. BMC Res Notes. 2017 Jul 24;10(1):310 [PMID: 28738895]
  22. Medicine (Baltimore). 2016 Aug;95(35):e4728 [PMID: 27583913]
  23. Physiother Theory Pract. 2019 Jan;35(1):40-56 [PMID: 29432058]
  24. Pain. 1997 Jun;71(2):135-40 [PMID: 9211474]
  25. Arch Gen Psychiatry. 2008 Feb;65(2):220-31 [PMID: 18250260]
  26. Nat Rev Rheumatol. 2018 Dec;14(12):727-740 [PMID: 30361674]
  27. Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:191-211 [PMID: 30216744]
  28. Pain. 2019 Jan;160(1):1-4 [PMID: 30086114]
  29. J Orthop Sports Phys Ther. 2017 May;47(5):301-304 [PMID: 28459190]
  30. Int Rev Neurobiol. 2018;139:107-128 [PMID: 30146044]
  31. Man Ther. 2016 Aug;24:65-74 [PMID: 27133031]
  32. Psychol Sci. 2007 Feb;18(2):165-71 [PMID: 17425538]
  33. Neuroimage. 2003 Aug;19(4):1738-47 [PMID: 12948728]
  34. Sci Transl Med. 2014 Jan 8;6(218):218ra5 [PMID: 24401940]
  35. Musculoskelet Sci Pract. 2019 Dec;44:102044 [PMID: 31358458]
  36. Lancet Neurol. 2016 Jun;15(7):736-747 [PMID: 27106073]
  37. Pain Rep. 2017 Mar-Apr;2(2): [PMID: 28971165]
  38. J Neurosci. 2011 Jan 12;31(2):439-52 [PMID: 21228154]
  39. Neuroimage. 1999 Jun;9(6 Pt 1):563-71 [PMID: 10334900]
  40. Spine J. 2017 Mar;17(3):445-456 [PMID: 27888138]
  41. Spine (Phila Pa 1976). 2014 Nov 1;39(23):1997 [PMID: 25365716]
  42. BMC Health Serv Res. 2015 Jul 22;15:277 [PMID: 26199147]
  43. Lancet. 1995 Nov 4;346(8984):1231 [PMID: 7475687]
  44. J Neurosci. 2008 Dec 3;28(49):13354-62 [PMID: 19052227]
  45. J Orthop Sports Phys Ther. 2018 Jan;48(1):8-18 [PMID: 29034802]
  46. Clin Pharmacol Ther. 2015 Feb;97(2):143-50 [PMID: 25670519]
  47. Lancet. 1955 Apr 2;268(6866):683-8 [PMID: 14354967]
  48. Sci Transl Med. 2011 Feb 16;3(70):70ra14 [PMID: 21325618]
  49. PLoS One. 2018 Aug 24;13(8):e0202211 [PMID: 30142199]
  50. Biol Psychiatry. 2016 May 15;79(10):794-802 [PMID: 26321018]
  51. Pain. 2003 Sep;105(1-2):17-25 [PMID: 14499416]
  52. Science. 2004 Feb 20;303(5661):1162-7 [PMID: 14976306]
  53. Adv Health Sci Educ Theory Pract. 2012 Mar;17(1):65-79 [PMID: 21505841]
  54. J R Soc Med. 2008 May;101(5):222-5 [PMID: 18463276]
  55. Int Rev Neurobiol. 2018;139:129-157 [PMID: 30146045]
  56. Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11056-61 [PMID: 17578917]
  57. Med Educ. 2011 Sep;45(9):927-38 [PMID: 21848721]
  58. Eur J Pain. 2015 Apr;19(4):546-53 [PMID: 25161110]
  59. Science. 2016 Nov 4;354(6312):584-587 [PMID: 27811269]
  60. Neuroimage. 2004 May;22(1):447-55 [PMID: 15110038]
  61. J Clin Nurs. 2015 Jul;24(13-14):1975-84 [PMID: 26032858]
  62. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S72-4 [PMID: 20083013]
  63. Spine J. 2012 Nov;12(11):1021-8 [PMID: 23158966]
  64. Adv Health Sci Educ Theory Pract. 2015 Dec;20(5):1225-36 [PMID: 25753295]
  65. Int Rev Neurobiol. 2018;139:297-319 [PMID: 30146052]
  66. Psychopharmacology (Berl). 2011 Feb;213(4):791-7 [PMID: 20931328]
  67. J Orthop Sports Phys Ther. 2013;43(7):439-41 [PMID: 23812031]
  68. Science. 2002 Mar 1;295(5560):1737-40 [PMID: 11834781]
  69. Pain Rep. 2017 Mar-Apr;2(2): [PMID: 29034363]
  70. Eur J Pain. 2014 Aug;18(7):914-22 [PMID: 24347563]
  71. Perspect Public Health. 2015 Sep;135(5):243-50 [PMID: 26187638]
  72. Eur J Neurosci. 2018 Dec;48(11):3410-3425 [PMID: 30362195]
  73. Nat Rev Drug Discov. 2013 Mar;12(3):191-204 [PMID: 23449306]
  74. Lancet. 2001 Mar 10;357(9258):757-62 [PMID: 11253970]
  75. PLoS One. 2016 Jun 30;11(6):e0158363 [PMID: 27362552]
  76. Nurse Educ Pract. 2020 Jan;42:102670 [PMID: 31775083]
  77. Eur J Neurosci. 2019 Oct;50(8):3311-3326 [PMID: 31209960]
  78. Lancet. 2010 Feb 20;375(9715):686-95 [PMID: 20171404]
  79. Phys Ther. 2013 Apr;93(4):479-91 [PMID: 23197846]
  80. Sci Rep. 2019 Apr 23;9(1):6408 [PMID: 31015560]
  81. Parkinsonism Relat Disord. 2019 Aug;65:184-189 [PMID: 31277983]
  82. J Neurosci. 2006 Nov 15;26(46):12014-22 [PMID: 17108175]
  83. Pain. 2015 Nov;156(11):2222-33 [PMID: 26181304]
  84. Pain. 2001 Jul;93(1):77-84 [PMID: 11406341]
  85. Neuroreport. 1998 Aug 3;9(11):2663-7 [PMID: 9721952]
  86. J Neurosci. 2002 Apr 15;22(8):3206-14 [PMID: 11943821]
  87. Health (London). 2020 May;24(3):315-340 [PMID: 30238795]
  88. J Neurosci. 2006 Apr 19;26(16):4437-43 [PMID: 16624963]
  89. Front Psychol. 2018 Oct 24;9:2041 [PMID: 30405506]
  90. Pain. 2014 May;155(5):921-8 [PMID: 24462931]
  91. Disabil Rehabil. 2017 Sep;39(19):1983-1989 [PMID: 27645805]
  92. Acad Med. 2010 May;85(5):894-901 [PMID: 20520047]
  93. Sci Rep. 2018 Aug 16;8(1):12296 [PMID: 30115945]
  94. Pain. 2008 May;136(1-2):211-8 [PMID: 18372113]
  95. Eur J Neurosci. 2015 Feb;41(4):492-7 [PMID: 25522899]
  96. J Orthop Sports Phys Ther. 2018 Nov;48(11):905-906 [PMID: 30381023]
  97. Int Rev Neurobiol. 2018;138:329-357 [PMID: 29681333]
  98. Scand J Caring Sci. 2012 Jun;26(2):394-403 [PMID: 21913950]
  99. Science. 2001 Aug 10;293(5532):1164-6 [PMID: 11498597]
  100. Front Psychiatry. 2019 Jul 04;10:478 [PMID: 31333519]
  101. Health Psychol. 2011 Jul;30(4):424-9; discussion 430-1 [PMID: 21574706]
  102. PLoS One. 2018 Nov 30;13(11):e0208159 [PMID: 30500838]
  103. Man Ther. 2009 Oct;14(5):531-8 [PMID: 19027342]
  104. Nat Med. 2010 Nov;16(11):1277-83 [PMID: 20948533]
  105. Chiropr Man Therap. 2017 Feb 13;25:6 [PMID: 28289539]
  106. Arch Physiother. 2018 Feb 17;8:3 [PMID: 29468089]
  107. Trends Neurosci. 2002 Jun;25(6):302-6 [PMID: 12086748]
  108. Nat Med. 2011 Oct 02;17(10):1228-30 [PMID: 21963514]
  109. Pain Pract. 2019 Apr;19(4):370-381 [PMID: 30457698]
  110. Eur J Pain. 2019 May;23(5):923-935 [PMID: 30620151]
  111. Eur J Pain. 2017 May;21(5):874-885 [PMID: 28106308]
  112. Qual Life Res. 2016 Jul;25(7):1625-34 [PMID: 26563249]
  113. Int Rev Neurobiol. 2018;139:255-296 [PMID: 30146050]
  114. Man Ther. 2013 Feb;18(1):60-4 [PMID: 22883130]
  115. Neuron. 2007 Jul 19;55(2):325-36 [PMID: 17640532]
  116. Pain. 2009 Jul;144(1-2):28-34 [PMID: 19278785]
  117. Neuropsychopharmacology. 2011 Jan;36(1):339-54 [PMID: 20592717]
  118. Pain Med. 2001 Dec;2(4):259-66 [PMID: 15102230]
  119. Pain. 1996 Mar;64(3):535-43 [PMID: 8783319]
  120. Pain. 2007 Jan;127(1-2):63-72 [PMID: 16963184]
  121. Pharmacol Rev. 2015 Jul;67(3):697-730 [PMID: 26126649]
  122. Clin Ther. 2017 Mar;39(3):469-476 [PMID: 28161116]
  123. J Neurosci. 1999 Jan 1;19(1):484-94 [PMID: 9870976]
  124. FASEB J. 2002 Dec;16(14):1869-73 [PMID: 12468450]
  125. Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1849-58 [PMID: 21576142]
  126. N Engl J Med. 2020 Feb 6;382(6):554-561 [PMID: 32023375]
  127. Annu Rev Neurosci. 2017 Jul 25;40:167-188 [PMID: 28399689]
  128. Sci Rep. 2018 Oct 3;8(1):14758 [PMID: 30283022]
  129. Neuroscience. 2016 Dec 3;338:19-26 [PMID: 26827944]
  130. Pain. 2010 Mar;148(3):368-74 [PMID: 19875233]
  131. Sci Rep. 2015 Jul 06;5:11774 [PMID: 26145718]
  132. Physiol Rev. 2013 Jul;93(3):1207-46 [PMID: 23899563]
  133. Eur J Neurol. 2017 Jan;24(1):143-153 [PMID: 27696633]
  134. J Manipulative Physiol Ther. 2005 Nov-Dec;28(9):662-6 [PMID: 16326235]
  135. Br J Sports Med. 2013 Jan;47(1):6-9 [PMID: 22893511]
  136. J Neurosci. 2003 May 15;23(10):4315-23 [PMID: 12764120]
  137. BMC Musculoskelet Disord. 2018 Jan 22;19(1):27 [PMID: 29357856]
  138. Pain Rep. 2019 Jun 07;4(3):e716 [PMID: 31583342]
  139. Pain. 2002 Apr;96(3):393-402 [PMID: 11973014]
  140. J Orthop Sports Phys Ther. 2008 Jun;38(6):293-5 [PMID: 18515964]
  141. J Bodyw Mov Ther. 2013 Jan;17(1):59-68 [PMID: 23294685]
  142. J Neurosci. 2006 Jan 11;26(2):381-8 [PMID: 16407533]
  143. Front Pharmacol. 2019 Mar 11;10:219 [PMID: 30914952]
  144. Disabil Rehabil. 2020 Feb;42(4):460-472 [PMID: 30428722]
  145. Chiropr Osteopat. 2009 Oct 12;17:10 [PMID: 19822008]
  146. Neuron. 2009 Aug 27;63(4):533-43 [PMID: 19709634]

Word Cloud

Created with Highcharts 10.0.0effectsnoceboplacebohealthcarecontextcontext-relatedphysiotherapyperspectivePlaceboneurophysiologicalmechanismsdifferentpsychoneurobiologicalvaluetriggerpsychologicalimpactinvolvedlearningstudiescortextherapyeffectBACKGROUND:embodyphenomenabehaviouralperceptivecognitivechangesoccurtherapeuticencounterproducedpositiveconsequencesnegativeHistoricallyconsideredconfoundingelementscliniciansresearcherslasttwodecadesattitudestartedchangeunderstandingincreasedDespitegrowinginterestknowledgeawarenessusingcurrentlylimitedheterogeneousamongphysiotherapistsreducingtranslationalfieldOBJECTIVES:introduceby:1presentingmodels2describing3underliningprofession4tracinglinesfutureresearchesCONCLUSION:SeveralincludingexpectationprocessesclassicalconditioningobservationalreinforcedexpectationsmindsetpersonalitytraitsmainlyincludeendogenousopioidendocannabinoiddopaminergicsystemsNeuroimagingidentifiedbrainregionsdorsolateralprefrontalrostralanteriorcingulateperiaqueductalgraydorsalhornspineclinicalmanipulationbestevidence-basedrepresentsopportunityavoidrespectingethicalcodeconductmanagerialstakeholdersorganizationsgovernmentsencourageassessmentaimedimprovequalityserviceseducationalprofessionaltopicsintegrateduniversityprogramhealthmedicalprofessionsresearchcontroloffersscientificcommunitychancebettermeasureoutcomesconditionsprimaryContextmatters:determinantsConditioningContextualfactorsExpectationLearningNoceboPainPhysicalmodalitiesRehabilitationTherapeuticoutcome

Similar Articles

Cited By